Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 129.
A
Agliardi, G;
Liuzzi, AR;
Hotblack, A;
De Feo, D;
Núñez, N;
Stowe, CL;
Friebel, E;
... Becher, B; + view all
(2021)
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma.
Nature Communications
, 12
, Article 444. 10.1038/s41467-020-20599-x.
|
 |
|
Ainley, L;
Chavda, SJ;
Counsell, N;
Cheesman, S;
Newrick, F;
Horder, J;
Kyriakou, C;
... Yong, K; + view all
(2021)
DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
British Journal of Haematology
, 192
(3)
e73-e77.
10.1111/bjh.17248.
|
|
Almarzouki, A;
Wilson, D;
Ambler, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
Al-Shahi Salman, R;
... Werring, DJ; + view all
(2021)
Publisher Correction: Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage.
Scientific Reports
, 11
(1)
, Article 9485. 10.1038/s41598-021-88890-5.
|
|
|
Ascierto, PA;
Blank, C;
Dummer, R;
Ernstoff, MS;
Ferrone, S;
Fox, BA;
Gajewski, TF;
... Thurin, M; + view all
(2021)
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
Journal of Translational Medicine
, 19
, Article 278. 10.1186/s12967-021-02951-x.
|
|
|
Au, L;
Hatipoglu, E;
Robert de Massy, M;
Litchfield, K;
Beattie, G;
Rowan, A;
Schnidrig, D;
... TRACERx Renal Consortium; + view all
(2021)
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell
, 39
pp. 1497-1518.
10.1016/j.ccell.2021.10.001.
|
|
|
Avenoso, D;
Marsh, JCW;
Potter, V;
Pagliuca, A;
Slade, S;
Dignan, F;
Tholouli, E;
... Kulasekararaj, AG; + view all
(2021)
SARS-CoV-2 infection in aplastic anaemia.
Haematologica
10.3324/haematol.2021.279928.
(In press).
|
B
|
Bailey, C;
Black, JRM;
Reading, JL;
Litchfield, K;
Turajlic, S;
McGranahan, N;
Jamal-Hanjani, M;
(2021)
Tracking Cancer Evolution through the Disease Course.
Cancer Discovery
, 11
(4)
pp. 916-932.
10.1158/2159-8290.CD-20-1559.
|
|
Balestrini, S;
Koepp, MJ;
Gandhi, S;
Rickman, HM;
Yen Shin, G;
Houlihan, CF;
Anders-Cannon, J;
... Sisodiya, SM; + view all
(2021)
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy.
Epilepsy & Behavior
, 115
, Article 107602. 10.1016/j.yebeh.2020.107602.
|
|
Batty, Paul;
Riddell, Anne;
Kitchen, Steve;
Sardo Infirri, Sofia;
Walker, Isobel;
Woods, Tim;
Jennings, Ian;
(2021)
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
Haemophilia
, 27
(3)
pp. 490-499.
10.1111/hae.14158.
|
|
Bekaii-Saab, TS;
Bridgewater, J;
Normanno, N;
(2021)
Practical considerations in screening for genetic alterations in cholangiocarcinoma.
Annals of Oncology
10.1016/j.annonc.2021.04.012.
(In press).
|
|
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
|
|
Bennett, CL;
(2021)
Switching between tolerance and immunity: Do counter-acting gene networks dictate Langerhans cell function in the skin?
BioEssays
, 43
(5)
, Article 2100072. 10.1002/bies.202100072.
|
|
|
Bentham, R;
Litchfield, K;
Watkins, TBK;
Lim, EL;
Rosenthal, R;
Martinez-Ruiz, C;
Hiley, CT;
... McGranahan, N; + view all
(2021)
Using DNA sequencing data to quantify T cell fraction and therapy response.
Nature
, 597
pp. 555-560.
10.1038/s41586-021-03894-5.
|
|
Best, JG;
Ambler, G;
Wilson, D;
Lee, K-J;
Lim, J-S;
Shiozawa, M;
Koga, M;
... Werring, DJ; + view all
(2021)
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
The Lancet Neurology
, 20
(4)
pp. 294-303.
10.1016/S1474-4422(21)00024-7.
|
|
Biasco, L;
Izotova, N;
Rivat, C;
Ghorashian, S;
Richardson, R;
Guvenel, A;
Hough, R;
... Amrolia, PJ; + view all
(2021)
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients.
Nature Cancer
, 2
pp. 629-64.
10.1038/s43018-021-00207-7.
|
|
Bichet, DG;
Torra, R;
Wallace, E;
Hughes, D;
Giugliani, R;
Skuban, N;
Krusinska, E;
... Nicholls, K; + view all
(2021)
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease.
Molecular Genetics and Metabolism Reports
, 28
, Article 100786. 10.1016/j.ymgmr.2021.100786.
|
|
|
Boyle, Eileen M;
Deshpande, Shayu;
Tytarenko, Ruslana;
Ashby, Cody;
Wang, Yan;
Bauer, Michael A;
Johnson, Sarah K;
... Walker, Brian A; + view all
(2021)
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Nature Communications
, 12
, Article 293. 10.1038/s41467-020-20524-2.
|
|
C
|
Camilleri, M;
Sive, J;
Wilson, W;
Pang, G;
Jenner, R;
Phillips, E;
Popat, R;
... Yong, K; + view all
(2021)
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial.
British Journal of Haematology
, 192
(1)
E14-E16.
10.1111/bjh.17168.
|
|
Camilleri, M;
Cuadrado, M;
Phillips, E;
Wilson, W;
Jenner, R;
Pang, G;
Kamora, S;
... Yong, K; + view all
(2021)
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
British Journal of Haematology
10.1111/bjh.17377.
(In press).
|
|
|
Carbó, JM;
León, TE;
Font-Díaz, J;
De la Rosa, JV;
Castrillo, A;
Picard, FR;
Staudenraus, D;
... Valledor, AF; + view all
(2021)
Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment.
Cancer Research
, 81
(4)
pp. 968-985.
10.1158/0008-5472.CAN-19-3360.
|
|
Carter, TJ;
Agliardi, G;
Lin, F-Y;
Ellis, M;
Jones, C;
Robson, M;
Richard-Londt, A;
... Chester, K; + view all
(2021)
Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation.
Small
, Article e2005241. 10.1002/smll.202005241.
(In press).
|
|
|
Chan, E;
Sammaraiee, Y;
Banerjee, G;
Martin, AF;
Farmer, S;
Cowley, P;
Sayal, P;
... Werring, DJ; + view all
(2021)
Neuropsychological and neuroimaging characteristics of classical superficial siderosis.
Journal of Neurology
, 268
pp. 4238-4247.
10.1007/s00415-021-10548-z.
|
|
Chowdary, Pratima;
Shapiro, Susan;
Makris, Mike;
Evans, Gillian;
Boyce, Sara;
Talks, Kate;
Dolan, Gerry;
... Nathwani, Amit; + view all
(2021)
Factor IX Expression within the Normal Range Prevents Spontaneous Bleeds Requiring Treatment Following FLT180a Gene Therapy in Patients with Severe Hemophilia B: Long-Term Follow- up Study of the B-Amaze Program.
Blood
, 138
(Supp 1)
, Article 3967. 10.1182/blood-2021-146546.
|
|
Cleary, M;
Davison, J;
Gould, R;
Geberhiwot, T;
Hughes, D;
Mercer, J;
Morrison, A;
... Stepien, KM; + view all
(2021)
Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England.
Orphanet Journal of Rare Diseases
, 16
, Article 38. 10.1186/s13023-021-01675-x.
|
|
|
Coats, T;
Bean, D;
Basset, A;
Sirkis, T;
Brammeld, J;
Johnson, S;
Thomas, I;
... Dillon, R; + view all
(2021)
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia.
British Journal of Haematology
10.1111/bjh.18013.
(In press).
|
|
|
Cohen, H;
Efthymiou, M;
Devreese, KMJ;
(2021)
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 19
(4)
pp. 892-908.
10.1111/jth.15217.
|
|
Cohen, H;
Isenberg, DA;
(2021)
How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
Blood
, 137
(3)
pp. 299-309.
10.1182/blood.2020004942.
|
|
Cohen, OC;
Brodermann, MH;
Dervin, A;
Raja, N;
Marafioti, T;
Otero, S;
Beale, T;
... Morley, S; + view all
(2021)
Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real‐World Experience from 554 sequential core biopsies from a single centre.
European Journal of Haematology
, 106
(2)
pp. 267-272.
10.1111/ejh.13545.
|
|
Cordoba, S;
Onuoha, S;
Thomas, S;
Pignataro, DS;
Hough, R;
Ghorashian, S;
Vora, A;
... Amrolia, PJ; + view all
(2021)
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial.
Nature Medicine
, 27
pp. 1797-1805.
10.1038/s41591-021-01497-1.
|
|
|
Creasey, T;
Barretta, E;
Ryan, SL;
Butler, E;
Kirkwood, AA;
Leongamornlert, D;
Papaemmanuil, E;
... Moorman, AV; + view all
(2021)
Genetic and genomic analysis of acute lymphoblastic leukaemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Haematologica
10.3324/haematol.2021.279177.
(In press).
|
|
|
Creasey, T;
Enshaei, A;
Nebral, K;
Schwab, C;
Watts, K;
Cuthbert, G;
Vora, A;
... Moorman, AV; + view all
(2021)
Single nucleotide polymorphism (SNP) array-based signature of low hypodiploidy in acute lymphoblastic leukemia.
Genes Chromosomes and Cancer
10.1002/gcc.22956.
(In press).
|
|
D
|
D'Amore, S;
Page, K;
Donald, A;
Taiyari, K;
Tom, B;
Deegan, P;
Tan, CY;
... MRC GAUCHERITE Consortium, .; + view all
(2021)
In-depth phenotyping for clinical stratification of Gaucher disease.
Orphanet Journal of Rare Diseases
, 16
(1)
, Article 431. 10.1186/s13023-021-02034-6.
|
|
|
Du, H;
Wilson, D;
Ambler, G;
Banerjee, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
... Clinical Relevance of Microbleeds in Stroke (CROMIS-2) Collabora, .; + view all
(2021)
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
Stroke
, 52
(1)
pp. 91-99.
10.1161/STROKEAHA.120.029474.
|
F
|
Fanelli, G;
Romano, M;
Nova-Lamperti, E;
Werner Sunderland, M;
Nerviani, A;
Scottà, C;
Bombardieri, M;
... Becker, PD; + view all
(2021)
PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype.
PLoS Biology
, 19
(4)
, Article e3001199. 10.1371/journal.pbio.3001199.
(In press).
|
|
|
Farah, Nadine Hani Rashad;
(2021)
Identifying novel therapeutic targets and prognostic markers through analysis of allele specific alterations in T-cell acute lymphoblastic leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Fendler, A;
Au, L;
Shepherd, STC;
Byrne, F;
Cerrone, M;
Boos, LA;
Rzeniewicz, K;
... Wilkinson, RJ; + view all
(2021)
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Nature Cancer
10.1038/s43018-021-00275-9.
(In press).
|
|
|
Ferrari, M;
Mekkaoui, L;
Ilca, FT;
Akbar, Z;
Bughda, R;
Lamb, K;
Ward, K;
... Onuoha, SC; + view all
(2021)
Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
Journal of Virology
, 95
(19)
, Article e00685-21. 10.1128/JVI.00685-21.
|
|
Fortmann, J;
Fisher, A;
Hough, R;
Gregory, A;
Pugh, G;
(2021)
Sleep Quality Among Teenagers and Young Adults With Cancer.
Cancer Nursing
, 44
(1/2)
pp. 13-19.
10.1097/NCC.0000000000000707.
|
|
Fox, TA;
Carpenter, B;
Taj, M;
Perisoglou, M;
Nicholson, E;
Castleton, A;
Elliot, J;
... Hough, R; + view all
(2021)
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma.
Leukemia & Lymphoma
, 62
(4)
pp. 1010-1012.
10.1080/10428194.2020.1855346.
|
|
Fox, TA;
Kirkwood, AA;
Enfield, L;
O'Reilly, M;
Arulogun, S;
D'Sa, S;
O'Nions, J;
... Morris, EC; + view all
(2021)
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.
British Journal of Haematology
, 195
(5)
pp. 706-709.
10.1111/bjh.17836.
|
 |
|
Fu, X;
Zhao, Y;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Bates, PA; + view all
(2021)
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study.
Nature Ecology & Evolution
10.1038/s41559-021-01586-x.
|
|
G
|
Gangoso, E;
Southgate, B;
Bradley, L;
Rus, S;
Galvez-Cancino, F;
McGivern, N;
Güç, E;
... Pollard, SM; + view all
(2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion.
Cell
10.1016/j.cell.2021.03.023.
(In press).
|
|
|
Garbowski, Maciej W;
Porter, John B;
Hider, Robert;
(2021)
Response to Cabantchik and Hershko commentary "Plasma nontransferrin bound iron-nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation".
American Journal of Hematology
, 97
(2)
E58-E59.
10.1002/ajh.26419.
|
|
Garcia-Diaz, Claudia;
Mereu, Elisabetta;
Clements, Melanie;
Pöysti, Anni;
Galvez-Cancino, Felipe;
Castillo, Simon;
Courtot, Lilas;
... Parrinello, Simona; + view all
(2021)
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumour bulk and infiltrative margin.
bioRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Ghamlouch, Hussein;
Boyle, Eileen M;
Blaney, Patrick;
Wang, Yubao;
Choi, Jinyoung;
Williams, Louis;
Bauer, Michael;
... Morgan, Gareth J; + view all
(2021)
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.
Journal of Experimental & Clinical Cancer Research
, 40
, Article 380. 10.1186/s13046-021-02185-1.
|
|
Gkrouzman, E;
Sevim, E;
Finik, J;
Andrade, D;
Pengo, V;
Sciascia, S;
Tektonidou, MG;
... APS ACTION+; + view all
(2021)
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Clinical Database and Repository.
Journal of Rheumatology
, 48
(4)
pp. 541-547.
10.3899/jrheum.200513.
|
|
Gleeson, M;
Counsell, N;
Cunningham, D;
Lawrie, A;
Clifton-Hadley, L;
Hawkes, E;
McMillan, A;
... Linch, D; + view all
(2021)
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial.
British Journal of Haematology
, 192
(6)
pp. 1015-1019.
10.1111/bjh.16691.
|
|
Glynne, P;
Tahmasebi, N;
Gant, V;
Gupta, R;
(2021)
Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines.
Journal of Investigative Medicine
10.1136/jim-2021-002051.
(In press).
|
|
|
Gopal, AK;
Popat, R;
Mattison, RJ;
Menne, T;
Bloor, A;
Gaymes, T;
Khwaja, A;
... Mufti, GJ; + view all
(2021)
A Phase I trial of talazoparib in patients with advanced hematologic malignancies.
International Journal of Hematologic Oncology
, 10
(3)
10.2217/ijh-2021-0004.
|
|
|
Goyal, L;
Kongpetch, S;
Crolley, VE;
Bridgewater, J;
(2021)
Targeting FGFR inhibition in cholangiocarcinoma.
Cancer Treatment Reviews
, 95
, Article 102170. 10.1016/j.ctrv.2021.102170.
|
|
Green, K;
Pavasovic, V;
Ghorashian, S;
Ancliff, P;
Bartram, J;
Rao, A;
Samarasinghe, S;
... O'Connor, D; + view all
(2021)
Clinical Utility of Radiologic Disease Reassessment in the Management of Pediatric B-Cell Non-Hodgkin Lymphoma.
Journal of Pediatric Hematology/Oncology
, 43
(3)
e380-e384.
10.1097/MPH.0000000000001781.
|
H
|
Hagos, YB;
Lecat, CSY;
Patel, D;
Lee, L;
Tran, TA;
Justo, MR;
Yong, K;
(2021)
Cell abundance aware deep learning for cell detection on highly imbalanced pathological data.
In:
2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI).
(pp. pp. 1438-1442).
IEEE: Nice, France.
|
|
|
Harrison, SJ;
Perrot, A;
Alegre, A;
Simpson, D;
Wang, MC;
Spencer, A;
Delimpasi, S;
... Richardson, P; + view all
(2021)
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.
British Journal of Haematology
10.1111/bjh.17499.
(In press).
|
|
|
Hayden, PJ;
Roddie, C;
Bader, P;
Basak, GW;
Bonig, H;
Bonini, C;
Chabannon, C;
... Yakoub-Agha, I; + view all
(2021)
Management of Adults and Children receiving CAR T-cell therapy: 2021 Best Practice Recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
Annals of Oncology
10.1016/j.annonc.2021.12.003.
(In press).
|
|
|
Hostettler, IC;
Schwarz, G;
Ambler, G;
Wilson, D;
Banerjee, G;
Seiffge, D;
Shakeshaft, C;
... Werring, DJ; + view all
(2021)
Cerebral Small Vessel Disease and Functional Outcome Prediction after Intracerebral Haemorrhage.
Neurology
, 96
(15)
e1954-e1965.
10.1212/WNL.0000000000011746.
|
|
Hotblack, A;
Kokalaki, EK;
Palton, MJ;
Cheung, GW-K;
Williams, IP;
Manzoor, S;
Grothier, TI;
... Pule, M; + view all
(2021)
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein-protein interaction.
Scientific Reports
, 11
(1)
, Article 21902. 10.1038/s41598-021-01418-9.
|
|
|
Hughes, D;
Linhart, A;
Gurevich, A;
Kalampoki, V;
Jazukeviciene, D;
Feriozzi, S;
(2021)
Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis.
Drug Design, Development and Therapy
, 15
pp. 3561-3572.
10.2147/DDDT.S313789.
|
|
K
|
Killick, SB;
Ingram, W;
Culligan, D;
Enright, H;
Kell, J;
Payne, EM;
Krishnamurthy, P;
... Bowen, D; + view all
(2021)
Guidelines for the management of adult myelodysplastic syndromes.
British Journal of Haematology
, 194
(2)
pp. 267-281.
10.1111/bjh.17612.
|
|
Killick, SB;
Wiseman, DH;
Quek, L;
Cargo, C;
Culligan, D;
Enright, H;
Green, S;
... Haematology, BSF; + view all
(2021)
Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes.
British Society of Haematology
, 194
(2)
pp. 282-293.
10.1111/bjh.17621.
|
|
Klopp, A;
Schreiber, S;
Kosinska, AD;
Pule, M;
Protzer, U;
Wisskirchen, K;
(2021)
Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B.
Frontiers in Immunology
, 12
, Article 734246. 10.3389/fimmu.2021.734246.
|
|
|
Kuhnl, A;
Roddie, C;
Kirkwood, AA;
Menne, T;
Cuadrado, MM;
Marzolini, MAV;
Osborne, W;
... Kayani, I; + view all
(2021)
Early FDG PET response predicts CAR-T failure in large B-cell lymphoma.
Blood Advances
10.1182/bloodadvances.2021005807.
(In press).
|
|
L
|
Lamarca, A;
Palmer, DH;
Wasan, HS;
Ross, PJ;
Ma, YT;
Arora, A;
Falk, S;
... Advanced Biliary Cancer Working Group; + view all
(2021)
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
The Lancet Oncology
10.1016/S1470-2045(21)00027-9.
(In press).
|
|
|
Lecat, CSY;
McCourt, O;
Land, J;
Yong, K;
Fisher, A;
(2021)
Multiple myeloma and physical activity.
BMC Research Notes
, 14
(1)
, Article 171. 10.1186/s13104-021-05591-y.
|
|
|
Lecat, CSY;
Taube, JBB;
Wilson, W;
Carmichael, J;
Parrish, C;
Wallis, G;
Kyriakou, C;
... Popat, R; + view all
(2021)
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma.
Frontiers in Oncology
, 11
, Article 703233. 10.3389/fonc.2021.703233.
|
|
|
Lechner, M;
Schartinger, VH;
Steele, CD;
Nei, WL;
Ooft, ML;
Schreiber, L-M;
Pipinikas, CP;
... Lund, VJ; + view all
(2021)
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Nature Communications
, 12
(1)
, Article 117. 10.1038/s41467-020-20308-8.
|
|
|
Lee, L;
Alrasheed, N;
Khandelwal, G;
Fitzsimons, E;
Richards, H;
Wilson, W;
Chavda, SJ;
... Yong, K; + view all
(2021)
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
Frontiers Immunology
, 12
, Article 618610. 10.3389/fimmu.2021.618610.
|
|
|
Lenogue, K;
Walencik, A;
Laulagnier, K;
Molens, J-P;
Benlalam, H;
Dreno, B;
Coulie, P;
... Plumas, J; + view all
(2021)
Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells.
Vaccines
, 9
(2)
, Article 141. 10.3390/vaccines9020141.
|
|
|
Li, Z;
Lamb, R;
Coles, MC;
Bennett, CL;
Ambler, CA;
(2021)
Inducible ablation of CD11c⁺ cells to determine their role in skin wound repair.
Immunology
, 163
(1)
pp. 105-111.
10.1111/imm.13312.
|
|
|
Lin, W-Y;
Fordham, SE;
Hungate, E;
Sunter, NJ;
Elstob, C;
Xu, Y;
Park, C;
... Allan, JM; + view all
(2021)
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Nature Communications
, 12
(1)
, Article 6233. 10.1038/s41467-021-26551-x.
|
|
|
Linch, DC;
Hills, RK;
Burnett, AK;
Russell, N;
Gale, RE;
(2021)
Therapy for isocitrate dehydrogenase 2 (IDH2)(R172)-mutant acute myeloid leukaemia.
British Journal of Haematology
10.1111/bjh.17981.
(In press).
|
|
|
Linch, DC;
Hills, RK;
Gilkes, A;
Burnett, AK;
Russell, N;
Gale, RE;
(2021)
Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemia.
Leukemia Research
, 108
, Article 106553. 10.1016/j.leukres.2021.106553.
|
|
Litchfield, K;
Reading, JL;
Puttick, C;
Thakkar, K;
Abbosh, C;
Bentham, R;
Watkins, TBK;
... Swanton, C; + view all
(2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.
Cell
, 184
(3)
596-614.e14.
10.1016/j.cell.2021.01.002.
|
|
|
Lubin, A;
Otterstrom, J;
Hoade, Y;
Bjedov, I;
Stead, E;
Whelan, M;
Gestri, G;
... Payne, E; + view all
(2021)
A versatile, automated and high-throughput drug screening platform for zebrafish embryos.
Biology Open
10.1242/bio.058513.
(In press).
|
|
|
Lukina, E;
Balwani, M;
Belmatoug, N;
Watman, N;
Hughes, D;
Gaemers, SJM;
Foster, MC;
... Peterschmitt, MJ; + view all
(2021)
Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials.
JIMD Reports
, 57
(1)
pp. 76-84.
10.1002/jmd2.12172.
|
|
|
Lyndon, D;
Davagnanam, I;
Wilson, D;
Jichi, F;
Merwick, A;
Bolsover, F;
Jager, HR;
... Werring, DJ; + view all
(2021)
MRI-visible perivascular spaces as an imaging biomarker in Fabry disease.
Journal of Neurology
, 268
pp. 872-878.
10.1007/s00415-020-10209-7.
|
M
|
Marzolini, MAV;
Wilson, AJ;
Sanchez, E;
Carpenter, B;
Chakraverty, R;
Hough, R;
Kottaridis, P;
... Peggs, KS; + view all
(2021)
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.
Transplantation and Cellular Therapy
, 27
(8)
682.e1-682.e12.
10.1016/j.jtct.2021.04.020.
|
|
Mayor, NP;
Wang, T;
Lee, SJ;
Kuxhausen, M;
Vierra-Green, C;
Barker, DJ;
Auletta, J;
... Marsh, SGE; + view all
(2021)
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation.
Journal of Clinical Oncology
10.1200/JCO.20.03643.
(In press).
|
|
|
McCourt, O;
Yong, K;
Ramdharry, G;
Fisher, A;
(2021)
Physical Activity During and After Haematological Cancer Treatment: A Cross-Sectional Survey of Haematology Healthcare Professionals in the United Kingdom.
Journal of Multidisciplinary Healthcare
, 14
pp. 1659-1671.
10.2147/JMDH.S295888.
|
|
|
McCulloch, R;
Lewis, D;
Crosbie, N;
Eyre, TA;
Bolam, S;
Arasaretnam, A;
Creasey, T;
... Rule, S; + view all
(2021)
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients.
British Journal of Haematology
10.1111/bjh.17363.
|
|
|
McNamara, MG;
Bridgewater, J;
Palmer, DH;
Faluyi, O;
Wasan, H;
Patel, A;
Ryder, WD;
... Valle, JW; + view all
(2021)
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
The Oncologist
, 26
(4)
e669-e678.
10.1002/onco.13598.
|
|
Mekkaoui, L;
Bentley, EM;
Ferrari, M;
Lamb, K;
Ward, K;
Karattil, R;
Akbar, Z;
... Pule, M; + view all
(2021)
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike.
Bio Protocol
, 11
(16)
, Article e4194. 10.21769/BioProtoc.4194.
|
|
|
Meric-Bernstam, F;
Bahleda, R;
Hierro, C;
Sanson, M;
Bridgewater, J;
Arkenau, H-T;
Tran, B;
... Goyal, L; + view all
(2021)
Futibatinib, an irreversible FGFR1-4 inhibitor, in patients with advanced solid tumors harboring FGF/FGFR aberrations: a phase I dose-expansion study.
Cancer Discovery
10.1158/2159-8290.CD-21-0697.
(In press).
|
|
|
Mikhaeel, NG;
Cunningham, D;
Counsell, N;
McMillan, A;
Radford, JA;
Ardeshna, KM;
Lawrie, A;
... Barrington, SF; + view all
(2021)
FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study.
British Journal of Haematology
, 192
(3)
pp. 504-513.
10.1111/bjh.16875.
|
|
Mitchell, RJ;
Kirkwood, AA;
Barretta, E;
Clifton-Hadley, L;
Lawrie, E;
Lee, S;
Leongamornlert, D;
... Fielding, AK; + view all
(2021)
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.
Blood Advances
, 5
(17)
pp. 3322-3332.
10.1182/bloodadvances.2021004430.
|
|
|
Moorman, Anthony;
Butler, Ellie;
Barretta, Emilio;
Kirkwood, Amy A;
Schwab, Claire;
Creasey, Thomas;
Leongamornlert, Daniel A;
... Enshaei, Amir; + view all
(2021)
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Leukemia
10.1038/s41375-021-01448-2.
(In press).
|
|
|
Moreau, P;
Kumar, SK;
Miguel, JS;
Davies, F;
Zamagni, E;
Bahlis, N;
Ludwig, H;
... Richardson, PG; + view all
(2021)
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
The Lancet Oncology
, 22
(3)
E105-E118.
10.1016/S1470-2045(20)30756-7.
|
|
Moreno Martínez, D;
Aguiar, P;
Auray-Blais, C;
Beck, M;
Bichet, D;
Burlina, A;
Cole, D;
... Hughes, D; + view all
(2021)
Standardising clinical outcomes measures for adult clinical trials in Fabry Disease: A global Delphi Consensus.
Molecular Genetics and Metabolism
, 132
(4)
pp. 234-243.
10.1016/j.ymgme.2021.02.001.
|
|
Munoz, CM;
Ahmed, K;
Thomas, M;
Cohen, H;
Alijotas-Reig, J;
Giles, I;
(2021)
Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic review.
Lupus
10.1177/09612033211061850.
(In press).
|
  |
|
Muñoz-Martínez, S;
Sapena, V;
Forner, A;
Nault, J-C;
Sapisochin, G;
Rimassa, L;
Sangro, B;
... Reig, M; + view all
(2021)
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
JHEP Reports
, Article 100260. 10.1016/j.jhepr.2021.100260.
(In press).
|
|
N
|
Nannini, F;
Senicar, L;
Parekh, F;
Kong, KJ;
Kinna, A;
Bughda, R;
Sillibourne, J;
... Onuoha, SC; + view all
(2021)
Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments.
MAbs
, 13
(1)
, Article 1864084. 10.1080/19420862.2020.1864084.
|
|
O
|
O'Nions, J;
Muir, L;
Zheng, J;
Rees-Spear, C;
Rosa, A;
Roustan, C;
Earl, C;
... McCoy, L; + view all
(2021)
SARS-CoV-2 antibody responses in patients with acute leukemia.
Leukemia
, 35
pp. 289-292.
10.1038/s41375-020-01103-2.
|
|
Ottaviano, G;
Baird, S;
Bonney, D;
Connor, P;
Cummins, M;
Evans, P;
Gibson, B;
... Vora, A; + view all
(2021)
The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.
British Journal of Haematology
, 192
(2)
e42-e44.
10.1111/bjh.17198.
|
P
|
Pacheco, R;
Quezada, SA;
Kalergis, AM;
Becker, MI;
Ferreira, J;
De Ioannes, AE;
(2021)
Allergens of the urushiol family promote mitochondrial dysfunction by inhibiting the electron transport at the level of cytochromes b and chemically modify cytochrome c1.
Biological Research
, 54
(1)
, Article 35. 10.1186/s40659-021-00357-z.
|
|
|
Paietta, E;
Roberts, KG;
Wang, V;
Gu, Z;
Buck, G;
Pei, D;
Cheng, C;
... Litzow, MR; + view all
(2021)
Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL.
Blood
, 138
(11)
pp. 948-958.
10.1182/blood.2020010144.
|
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
|
|
Peña, OA;
Lubin, A;
Hockings, C;
Rowell, J;
Jung, Y;
Hoade, Y;
Dace, P;
... Payne, EM; + view all
(2021)
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling.
Blood Advances
, 5
(20)
pp. 4112-4124.
10.1182/bloodadvances.2020003055.
|
|
|
Peña, OA;
Lubin, A;
Rowell, J;
Hoade, Y;
Khokhar, N;
Lemmik, H;
Mahony, C;
... Payne, EM; + view all
(2021)
Differential Requirement of Gata2a and Gata2b for Primitive and Definitive Myeloid Development in Zebrafish.
Frontiers in Cell and Developmental Biology
, 9
, Article 708113. 10.3389/fcell.2021.708113.
|
|
|
Pocock, R;
Farah, N;
Richardson, SE;
Mansour, MR;
(2021)
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemia.
British Journal of Haematology
10.1111/bjh.17310.
(In press).
|
|
|
Popat, R;
Counsell, N;
De Tute, R;
De-Silva, D;
Phillips, EH;
Cavenagh, JD;
Adedayo, T;
... Yong, K; + view all
(2021)
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.
British Journal of Haematology
, 193
(3)
e19-e22.
10.1111/bjh.17391.
|
|
Porter, J;
Taher, A;
Viprakasit, V;
Kattamis, A;
Coates, TD;
Garbowski, M;
Durrenberger, F;
... Cappellini, MD; + view all
(2021)
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
Expert Review of Hematology
, 14
(7)
pp. 633-644.
10.1080/17474086.2021.1935854.
|
|
|
Privolizzi, R;
Chu, WS;
Tijani, M;
Ng, J;
(2021)
Viral gene therapy for paediatric neurological diseases: progress to clinical reality.
Developmental Medicine & Child Neurology
10.1111/dmcn.14885.
(In press).
|
|
R
|
Ramaswami, U;
D'Amore, S;
Finnegan, N;
Hughes, D;
Kazemi, M;
(2021)
Impact of SARS-CoV-2 (COVID-19) pandemic on patients with lysosomal storage disorders and restoration of services: experience from a specialist centre.
Internal Medicine Journal
10.1111/imj.15473.
(In press).
|
|
|
Ramirez, GA;
Mackie, I;
Nallamilli, S;
Pires, T;
Moll, R;
Pericleous, C;
Isenberg, DA;
... Efthymiou, M; + view all
(2021)
Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Rheumatology
, 60
(3)
pp. 1376-1386.
10.1093/rheumatology/keaa509.
|
|
Ramiro, Laura;
García-Berrocoso, Teresa;
Briansó, Ferran;
Goicoechea, Leire;
Simats, Alba;
Llombart, Víctor;
Gonzalo, Ricardo;
... Montaner, Joan; + view all
(2021)
Integrative Multi-omics Analysis to Characterize Human Brain Ischemia.
Molecular Neurobiology
, 58
(8)
pp. 4107-4121.
10.1007/s12035-021-02401-1.
|
|
Rampotas, A;
Wilson, MR;
Lomas, O;
Denny, N;
Leary, H;
Ferguson, G;
McKay, P;
... Eyre, TA; + view all
(2021)
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.
British Journal of Haematology
, 194
(2)
pp. 365-377.
10.1111/bjh.17513.
|
|
Rapetto, F;
Taliotis, D;
Chen, Q;
Ttofi, I;
Iacobazzi, D;
Madeddu, P;
Stoica, SC;
... Caputo, M; + view all
(2021)
Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch Operation.
JACC: Case Reports
, 3
(5)
pp. 724-727.
10.1016/j.jaccas.2021.02.039.
|
|
|
Reading, JL;
Roobrouck, VD;
Hull, CM;
Becker, PD;
Beyens, J;
Valentin-Torres, A;
Boardman, D;
... Tree, T; + view all
(2021)
Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects via Adult Progenitor Cell Co-Culture.
Frontiers in Immunology
, 12
, Article 716606. 10.3389/fimmu.2021.716606.
|
|
|
RECOVERY Collaborative Group;
(2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
The Lancet
, 397
(10289)
pp. 2049-2059.
10.1016/S0140-6736(21)00897-7.
|
|
|
Richardson, PG;
Harrison, SJ;
Bringhen, S;
Schjesvold, F;
Yong, K;
Campana, F;
Le-Guennec, S;
... Dimopoulos, MA; + view all
(2021)
Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study.
Future Oncology
, 17
(34)
pp. 4797-4812.
10.2217/fon-2021-0568.
|
|
|
Roddie, C;
Dias, J;
O'Reilly, MA;
Abbasian, M;
Cadinanos-Garai, A;
Vispute, K;
Bosshard-Carter, L;
... Peggs, KS; + view all
(2021)
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
10.1200/jco.21.00917.
(In press).
|
|
S
|
Salisbury, Richard A;
Curto-Garcia, Natalia;
O'Sullivan, Jennifer;
Chen, Frederick;
Polzella, Paolo;
Godfrey, Anna L;
Russell, James;
... Innes, Andrew J; + view all
(2021)
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Leukemia
, 35
pp. 2424-2430.
10.1038/s41375-021-01143-2.
|
|
Samarkanova, Dinara;
Cox, Steven;
Hernandez, Diana;
Rodriguez, Luciano;
Luisa Perez, Maria;
Madrigal, Alejandro;
Vilarrodona, Anna;
... Casaroli-Marano, Ricardo P; + view all
(2021)
Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties.
Scientific Reports
, 11
, Article 13754. 10.1038/s41598-021-93150-7.
|
|
|
Sayar, Z;
Moll, R;
Isenberg, D;
Cohen, H;
(2021)
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
Thrombosis Research
, 198
pp. 213-221.
10.1016/j.thromres.2020.10.010.
|
|
|
Sayar, Z;
Nallamilli, S;
Efthymiou, M;
Lambert, J;
Cohen, H;
(2021)
Coexistent antiphospholipid syndrome and myeloproliferative neoplasm.
Lupus
, 30
(9)
pp. 1502-1508.
10.1177/09612033211021154.
|
|
|
Seiffge, DJ;
Wilson, D;
Ambler, G;
Banerjee, G;
Hostettler, IC;
Houlden, H;
Shakeshaft, C;
... Werring, DJ; + view all
(2021)
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-325299.
(In press).
|
|
|
Selvadurai, S;
Mann, K;
Mithra, S;
Bridgewater, J;
Malik, H;
Khan, SA;
(2021)
Cholangiocarcinoma miscoding in hepatobiliary centres.
European Journal of Surgical Oncology
, 47
(3)
pp. 635-639.
10.1016/j.ejso.2020.09.039.
|
|
Simini, G;
Mackenzie, S;
Gohil, S;
Papanikolaou, X;
Manson, J;
Payne, E;
(2021)
Successful use of allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome presenting with autoimmune manifestations.
British Society of Haematology
, 193
(6)
pp. 1275-1277.
10.1111/bjh.17437.
|
T
|
Tait, A;
Proctor, T;
Hamilton, NJI;
Birchall, MA;
Lowdell, MW;
(2021)
GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering.
Scientific Reports
, 11
(1)
, Article 12392. 10.1038/s41598-021-91939-0.
|
|
|
Turati, VA;
Guerra-Assunção, JA;
Potter, NE;
Gupta, R;
Ecker, S;
Daneviciute, A;
Tarabichi, M;
... Enver, T; + view all
(2021)
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia.
Nature Cancer
, 2
pp. 835-852.
10.1038/s43018-021-00219-3.
|
V
|
van de Donk, NWCJ;
Pawlyn, C;
Yong, KL;
(2021)
Multiple myeloma.
The Lancet
, 397
(10272)
pp. 410-427.
10.1016/S0140-6736(21)00135-5.
|
|
Vithayathil, M;
Bridgewater, J;
Khan, SA;
(2021)
Medical therapies for intra-hepatic cholangiocarcinoma.
Journal of Hepatology
, 75
(4)
pp. 981-983.
10.1016/j.jhep.2021.04.004.
|
W
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DL; + view all
(2021)
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
The Lancet
10.1016/S0140-6736(21)01462-8.
(In press).
|
|
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DLV; + view all
(2021)
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
The Lancet
10.1016/s0140-6736(21)01290-3.
(In press).
|
|
|
Wawrzyniecka, PA;
Ibrahim, L;
Gritti, G;
Pule, MA;
Maciocia, PM;
(2021)
Chimeric antigen receptor T cells for gamma-delta T cell malignancies.
Leukemia
10.1038/s41375-021-01385-0.
(In press).
|
|
Y
|
Yeo, GHT;
Juez, O;
Chen, Q;
Banerjee, B;
Chu, L;
Shen, MW;
Sabry, M;
... Gifford, DK; + view all
(2021)
Detection of gene cis-regulatory element perturbations in single-cell transcriptomes.
PLoS Computational Biology
, 17
(3)
, Article e1008789. 10.1371/journal.pcbi.1008789.
(In press).
|
|
|
Yong, KL;
Hinsley, S;
Auner, HW;
Bygrave, C;
Kaiser, MF;
Ramasamy, K;
De Tute, RM;
... Brown, SR; + view all
(2021)
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multi-centre, phase II, randomized, controlled trial (MUKfive).
Haematologica
10.3324/haematol.2021.278399.
(In press).
|
|
Z
|
Zhao, Y;
Fu, X;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Litchfield, K; + view all
(2021)
Selection of metastasis competent subclones in the tumour interior.
Nature Ecology & Evolution
, 5
pp. 1033-1045.
10.1038/s41559-021-01456-6.
|
|
|
Zhu, AX;
Macarulla, T;
Javle, MM;
Kelley, RK;
Lubner, SJ;
Adeva, J;
Cleary, JM;
... Abou-Alfa, GK; + view all
(2021)
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
JAMA Oncology
10.1001/jamaoncol.2021.3836.
(In press).
|
|
|
Ziff, Monica;
Lawson, Gabrielle;
De-Silva, Dunnya;
Cheesman, Simon;
Kyriakou, Charalampia;
Mahmood, Shameem;
Papanikolaou, Xenofon;
... Popat, Rakesh; + view all
(2021)
Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set.
Leukemia & Lymphoma
, 62
(5)
pp. 1243-1246.
10.1080/10428194.2020.1864356.
|
